NR3C2 and Parkinson disease: In the whole study cohort, female sex, atrial fibrillation, and being a new user of at least one of the three medication classes were associated with increased probability of non-persistence, while increasing age, history of MI, Parkinson’s disease, increasing overall number of medications, and administration of beta-blockers and mineralocorticoid receptor antagonists were associated with persistence.